India Pesticides Ltd

- India Pesticides Limited plans to fund its Capex of Rs.110 crores for FY25 through **internal accruals**. - No mention of any **new fundraising through debt or equity** in the provided transcript. - Capex is split as Rs.50 crores for Sandila and Rs.60 crores for Hamirpur. - The company is focusing on expansion funded by their **own cash flows** and operational profits. - Cash and cash equivalents at the end of Q2 FY25 were Rs.127 crores, indicating sufficient liquidity. Thus, based on the call, there are **no current or future plans announced for raising funds via debt or equity**.

- FY25 Capex plan of Rs. 110 crores combining India Pesticides Limited (IPL) and Shalvis Specialty Chemicals (SSL). - Rs. 50 crores Capex allocated for Sandila plant and Rs. 60 crores for Hamirpur plant. - Rs. 20 crores Capex incurred during H1 FY25; Rs. 15 crores spent on Hamirpur blocks till September. - Total Capex for Hamirpur two blocks estimated at Rs. 40-42 crores, with Rs. 25-30 crores already spent on infrastructure. - Capacity expansion ongoing at Sandila and Hamirpur facilities to boost infrastructure and specialty product production capabilities. - Plans to commission Hamirpur plant blocks starting Q1 FY26, adding ~300 tonnes per annum per block. - Additional land is available for expansion around Hamirpur and adjacent Sandila sites. - Capex funding planned through internal accruals.

- **Revenue Growth**: Expected to increase with a 15-20% rise at existing plants; Hamirpur facility projected to contribute Rs.50-60 crores in FY26, with potential to reach Rs.700-800 crores after full expansion in 3-4 years. - **Volume Growth**: Technical volumes increased by ~30% YoY; formulation volumes rose by ~40%, with formulation expected to grow at least 20% annually. - **Capacity Expansion**: Capex of Rs.110 crores planned for FY25 split between Sandila (Rs.50 crores) and Hamirpur (Rs.60 crores); continuous additions of blocks at Hamirpur facility. - **Market Expansion**: Broadening customer base in regulated markets and over 25 countries; formulation presence expanding across Indian states. - **Product Pipeline & R&D**: Focus on innovation and backward integration to improve margins and volumes; new molecule growth expected above 10%. - **Operational Efficiency**: Process optimizations and stable raw material prices expected to support higher EBITDA margins (~18-20%) in H2 FY25.

- Company expects revenue growth driven by capacity expansion at Hamirpur and Sandila plants, targeting Rs.700-800 crores revenue at full Hamirpur utilization in 3-4 years. - Formulation segment projected to grow at over 20% annually, supported by increased product portfolio and geographic expansion. - Q2 FY25 EBITDA margin improved to 17%; management confident of achieving 18-20% EBITDA margin in H2 FY25 through process optimization and R&D efficiencies. - Capex of Rs.110 crores planned for FY25, fueling capacity and capability enhancements, funded via internal accruals. - Net profit for Q2 FY25 increased 33% YoY; expected to improve further with stable raw material prices and operational efficiencies. - Focus on expanding customer base in regulated markets and over 25 countries worldwide supports sustained revenue and margin growth. - R&D-driven product innovations to maintain competitive edge and margin expansion.

- The transcript does not explicitly mention the current or expected order book or pending orders for India Pesticides Limited. - However, the company indicates growing demand and commitments from customers, particularly for new products in the insecticide segment. - Customers have shown interest and soft commitments on certain products, though exact volumes and prices are under discussion. - The company plans continuous innovation and capacity expansion (e.g., Hamirpur plant blocks) to meet increasing volume growth and diversify products. - There is a focus on securing larger volumes with existing and new customers, including a Japanese company partnership with potential for future growth. - Expansion of formulation capacity and increased domestic and export market penetration suggest a positive order pipeline outlook.